Northwest Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-65
Closed -$3.36K – 161
2024
Q3
$3.36K Buy
+65
New +$3.05K ﹤0.01% 471
2024
Q1
– Sell
-523
Closed -$26.8K – 139
2023
Q4
$26.8K Buy
+523
New +$27.5K 0.02% 274

Other funds holding BMY

Northwest Financial Advisors's BMY Position: Q4 2024 in Review

Northwest Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 65 shares — an estimated $3.36K sold.

Northwest Financial Advisors first reported a position in BMY in Q4 2023 and held it in 2 quarters. The position peaked at $26.8K in Q4 2023. 2,494 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Northwest Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
  • Northwest Financial Advisors sold 65 Bristol-Myers Squibb shares in Q4 2024, an estimated $3.36K.
  • Northwest Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 2 quarters.
  • Northwest Financial Advisors's Bristol-Myers Squibb position peaked at $26.8K in Q4 2023.
  • 2,494 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Northwest Financial Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.